HIV and pulmonary arterial hypertension: a systematic review

Autor: BS Quon, John R. Swiston, Surinder Janda

Publikováno v: HIV Medicine. 11:620-634

Objectives HIV-related pulmonary arterial hypertension (PAH) is a rare entity but is associated with significant morbidity and mortality. The literature describing the outcomes of therapy for this disease is limited to case series and cohort studies.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e84df1b170d67d344448b80d28ac01be
https://doi.org/10.1111/j.1468-1293.2010.00829.x

Reduction in 3-Year Risk of Death or Lung Transplantation for Individuals with Advanced CF Lung Disease Treated with Elexacaftor/Tezacaftor/Ivacaftor.

Autor: Love AJ; St Paul's Hospital, Adult Cystic Fibrosis Clinic, Vancouver, British Columbia, Canada., Desai S; The University of British Columbia Centre for Heart Lung Innovation, School of Population and Public Health, Vancouver, British Columbia, Canada., Cheng SY; Cystic Fibrosis Canada, Toronto, Ontario, Canada., Stephenson AL; St. Michael's Hospital , Division of Respirology, Adult Cystic Fibrosis Centre, Toronto, Ontario, Canada.; University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.; St Michael's Hospital Keenan Research Centre for Biomedical Science, Toronto, Ontario, Canada.; University of Toronto Temerty Faculty of Medicine, Institute of Health Policy, Management and Evaluation, Toronto, Ontario, Canada., Stanojevic S; Dalhousie University Department of Community Health and Epidemiology, Halifax, Nova Scotia, Canada., Franciosi AN; St Paul's Hospital, Adult Cystic Fibrosis Clinic, Vancouver, British Columbia, Canada.; The University of British Columbia Centre for Heart Lung Innovation, Vancouver, British Columbia, Canada.; The University of British Columbia - Vancouver Campus, Medicine, Vancouver, British Columbia, Canada.; University College Dublin - National University of Ireland, Dublin, Ireland., Quon BS; University of British Columbia, Department of Medicine, Vancouver, British Columbia, Canada.; The University of British Columbia Centre for Heart Lung Innovation, Vancouver, British Columbia, Canada.; St Paul's Hospital, Adult Cystic Fibrosis Clinic, Vancouver, British Columbia, Canada; Bradley.Quon@hli.ubc.ca.

Publikováno v: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2024 Oct 31. Date of Electronic Publication: 2024 Oct 31.

Measuring the burden of cystic fibrosis: A scoping review.

Autor: Cheema ZM; Department of Medicine, McMaster University, Hamilton, Canada; Cystic Fibrosis Canada, Toronto, Canada., Gomez LC; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada., Johnson N; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada., Laflamme OD; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada., Rabin HR; Department of Medicine, Cumming School of Medicine at the University of Calgary, Calgary, Canada., Steele K; Cystic Fibrosis Canada, Toronto, Canada., Wallenburg J; Cystic Fibrosis Canada, Toronto, Canada., Leong J; Department of Medicine, Cumming School of Medicine at the University of Calgary, Calgary, Canada., Cheng SY; Cystic Fibrosis Canada, Toronto, Canada., Quon BS; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada., Stephenson AL; Division of Respirology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada., Wranik WD; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada; Department of Public and International Affairs, Faculty of Management, Dalhousie University, Halifax, Canada., Sadatsafavi M; Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada., Stanojevic S; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada. Electronic address: Sanja.Stanojevic@dal.ca.

Publikováno v: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Sep; Vol. 23 (5), pp. 823-830. Date of Electronic Publication: 2023 Dec 03.

Socioeconomic burden of cystic fibrosis in Canada.

Autor: Laflamme OD; Department of Community Health, and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada., Johnson N; Department of Community Health, and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada., Steele K; Cystic Fibrosis Canada, Toronto, Ontario, Canada., Chavez L; Department of Community Health, and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada., Cheng SY; Cystic Fibrosis Canada, Toronto, Ontario, Canada., Rabin HR; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Cheema ZM; Cystic Fibrosis Canada, Toronto, Ontario, Canada.; Department of Medicine, Hamilton, Hamilton, Ontario, Canada., Mamic E; Cystic Fibrosis Canada, Toronto, Ontario, Canada., Gomez LC; Department of Community Health, and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada., Leong J; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Quon BS; Division of Respiratory Medicine, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada., Sadatsafavi M; Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada., Stephenson AL; Division of Respirology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Wranik WD; Department of Community Health, and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.; Department of Public and International Affairs, Dalhousie University, Halifax, Nova Scotia, Canada., Eckford PDW; Cystic Fibrosis Canada, Toronto, Ontario, Canada., Wallenburg J; Cystic Fibrosis Canada, Toronto, Ontario, Canada., Bowerman C; Department of Community Health, and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.; Department of Medicine, Hamilton, Hamilton, Ontario, Canada., Stanojevic S; Department of Community Health, and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada sanja.stanojevic@dal.ca.

Publikováno v: BMJ open respiratory research [BMJ Open Respir Res] 2024 Aug 09; Vol. 11 (1). Date of Electronic Publication: 2024 Aug 09.

Assessing the impact of elexacaftor/tezacaftor/ivacaftor on anxiety & depression symptom scores in adults with Cystic Fibrosis.

Autor: Nguyen M; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., MacDiarmid P; Adult Cystic Fibrosis Program, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada., Tanzler A; Adult Cystic Fibrosis Program, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada., Dagenais R; Adult Cystic Fibrosis Program, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada; Department of Pharmacy, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada., Bevanda C; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Quon BS; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada. Electronic address: bradley.quon@hli.ubc.ca.

Publikováno v: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Jul 20. Date of Electronic Publication: 2024 Jul 20.